Current NDC auxiliary source row compounder:82

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 26436-5044
Product Ndc: 26436-5044
Product Ndc Digits: 264365044
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Procaine 2%
Proprietary Name Suffix: [empty]
Nonproprietary Name: Procaine 2%
Dosage Form Name: INJECTION
Route Name: INTRAMUSCULAR
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: Hybrid Pharma
Establishment Name: Hybrid Pharma
Establishment Fei: [empty]
Substance Name: PROCAINE HYDROCHLORIDE
Active Ingredients Info: 20 mg/1 mL
History Active Ingredients Raw: PROCAINE HYDROCHLORIDE
History Active Ingredients Info Raw: 20 mg/1 mL
History Dosage Raw: INJECTION
Dea Schedule: [empty]
Package Ndc Raw: 26436-5044-3
Package Ndc: 26436-5044-3
Package Ndc Digits: 2643650443
Package Ndc11: 26436504403
Package Description: 30 mL in 1 VIAL, GLASS (26436-5044-3)
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:82
Source Row Number: 82
Source Row Hash: 81948ecf2133f96258fd05c806cfd8ed211196e92257c46eaff4d902d7f42b06
Import Run Id: 20261013T114159Z
Loaded At: 2026-10-13 11:48:09

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRAMUSCULAR",
    "PRODUCTNDC": "26436-5044",
    "DEASCHEDULE": "",
    "LABELERNAME": "Hybrid Pharma",
    "SUBSTANCENAME": "PROCAINE HYDROCHLORIDE",
    "DOSAGEFORMNAME": "INJECTION",
    "NDCPACKAGECODE": "26436-5044-3",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Procaine 2%",
    "REPORTINGPERIOD": "2025-1",
    "NONPROPRIETARYNAME": "Procaine 2%",
    "PACKAGEDESCRIPTION": "30 mL in 1 VIAL, GLASS (26436-5044-3) ",
    "ACTIVEINGREDIENTSINFO": "20 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:82
Source Row Number: 82
Status Scope: package
Lookup Ndc: 26436-5044-3
Lookup Ndc Digits: 2643650443
Product Ndc: 26436-5044
Product Ndc Digits: 264365044
Package Ndc: 26436-5044-3
Package Ndc Digits: 2643650443
Package Ndc11: 26436504403
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2025-1
Reporting Period: 2025-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 81948ecf2133f96258fd05c806cfd8ed211196e92257c46eaff4d902d7f42b06
Import Run Id: 20261013T114159Z
Loaded At: 2026-10-13 11:48:09